TOPAMAX Film Coated Tablet 25 Milligram

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Buy It Now

Active ingredient:

TOPIRAMATE

Available from:

Profind Wholesale Ltd.

Dosage:

25 Milligram

Pharmaceutical form:

Film Coated Tablet

Authorization date:

2010-02-26

Summary of Product characteristics

                                IRISH MEDICINES BOARD ACT 1995, AS AMENDED
MEDICINAL PRODUCTS (CONTROL OF PLACING ON THE MARKET) REGULATIONS, 2007, AS AMENDED
PPA1500/050/001
Case No: 2083758
The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to
PROFIND WHOLESALE LTD.
UNIT 625, KILSHANE AVENUE, NORTHWEST BUSINESS PARK, DUBLIN 15, IRELAND
an authorisation, subject to the provisions of the said Regulations, in respect of the product
TOPAMAX 25MG FILM-COATED TABLETS
the particulars of which are set out in the attached Schedule. The authorisation is also subject to the general conditions as may be specified in
the said Regulations as listed on the reverse of this document.
This authorisation, unless previously revoked, shall continue in force from 28/07/2010.
Signed on behalf of the Irish Medicines Board this
________________
A person authorised in that behalf by the said Board.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 28/07/2010_
_CRN 2083758_
_page number: 1_
PART II
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Topamax 25mg Film-coated Tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 25mg topiramate.
Excipients: contains lactose monohydrate
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Film-coated tablet.
_Product imported from _Greece:
White, embossed, round, film-coated tablets imprinted with “TOP” on one side and “25” on the other.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
EPILEPSY
Topamax is indicated as monotherapy or adjunctive therapy for adults and children over 4 years of age for partial onset
seizures with or without secondarily generalised seizures and primary gener
                                
                                Read the complete document
                                
                            

Search alerts related to this product